Mishra 2019 Bio Protoc

From Bioblast
Revision as of 21:07, 23 August 2021 by Gnaiger Erich (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Publications in the MiPMap
Mishra P, Zhang T, Guo M, Chan D (2019) Mitochondrial respiratory measurements in patient-derived fibroblasts. Bio Protoc 9:e3446. doi: 10.21769/BioProtoc.3446

Β» PMID: 33654941 Open Access

Mishra P, Zhang T, Guo M, Chan D (2019) Bio Protoc

Abstract: Mitochondrial dysfunction is associated with a number of human diseases. As an example, we recently established in vivo Drosophila models of IBMPFD (Inclusion body myopathy, Paget disease, and frontotemporal dementia), and uncovered that human disease mutations of the p97/VCP (Valosin Containing Protein) gene behave as hyperactive alleles associated with mitochondrial defects. Pharmacologic inhibition of VCP strongly suppressed disease and mitochondrial pathology in these animal models. In this protocol, we describe a method to evaluate mitochondrial respiratory function in IBMPFD patient-derived fibroblasts, as well as investigate the role of pharmacologic treatments. These experiments complement work done in animal models by investigating mitochondrial biology and the pharmacologic response in a human cell-based model of the disease. In principle, this technique can be used to investigate mitochondrial respiratory function for any disease in which patient-derived fibroblasts are available.

β€’ Bioblast editor: Gnaiger E


Labels: MiParea: Respiration, Instruments;methods, nDNA;cell genetics 


Organism: Human  Tissue;cell: Fibroblast  Preparation: Intact cells 


Coupling state: LEAK, ROUTINE, ET  Pathway: ROX 



Cookies help us deliver our services. By using our services, you agree to our use of cookies.